Identification of novel biomarkers for lupus nephritis
Open Access
- 8 July 2024
- journal article
- research article
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 25 (2) , 406-424
Abstract
Lupus nephritis (LN) is an autoimmune disease that rapidly progresses as a secondary consequence of systemic lupus erythematosus (SLE) and has a very poor prognosis. Therefore, this study aimed to identify characteristics of immune cell infiltration and investigate potential therapeutic targets using bioinformatics methods and the Murphy Roths Large/lymphoproliferation (MRL/lpr) mouse model. In this study, a total of 2,810 differentially expressed genes (DEGs) were identified, which were primarily enriched in inflammatory and immune regulation pathways. From these DEGs, 226 immune-related genes (IRGs) were also identified. The single-sample gene set enrichment analysis (ssGSEA) revealed that patients with LN had increased infiltration of effector memory CD4+ T cells, effector memory CD8+ T cells, gamma delta T cells, myeloid-derived suppressor cells (MDSC), follicular helper T cells, Th1 cells, and Th2 cells, and this was closely correlated with the DEG-IRGs. Furthermore, the potential therapeutic biomarkers, CD244, S100 calcium binding protein P (S100P), and vascular endothelial growth factor C (VEGFC), were identified by Random Forest Approach (RFA), which were validated in LN mice. These findings provide new evidence and insights for further research on diagnosis and treatment of LN by identifying critical genes and their associations with immune infiltration.Keywords
This publication has 40 references indexed in Scilit:
- Inhibition of glutaminolysis ameliorates lupus by regulating T and B cell subsets and downregulating the mTOR/P70S6K/4EBP1 and NLRP3/caspase-1/IL-1β pathways in MRL/lpr miceInternational Immunopharmacology, 2022
- Th17 and Th1 cells in systemic lupus erythematosus with focus on lupus nephritisImmunologic Research, 2022
- Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's diseaseRheumatology International, 2021
- Update on the cellular and molecular aspects of lupus nephritisClinical Immunology, 2020
- Bioinformatics for Cancer Immunotherapy2020
- CD4+ T-Cell Differentiation In Vitro2020
- An update on potentials and promises of T cell co‐signaling molecules in transplantationJournal of Cellular Physiology, 2019
- T cells and IL-17 in lupus nephritisClinical Immunology, 2017
- High-affinity interaction between interleukin-11 and S100P proteinBiochemical and Biophysical Research Communications, 2015
- Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4–Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus ErythematosusArthritis & Rheumatology, 2015